Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02752074
Brief Title: A Phase 3 Study of Pembrolizumab + Epacadostat or Placebo in Subjects With Unresectable or Metastatic Melanoma (Keynote-252 / ECHO-301)

First Submitted : April 22, 2016
First Submitted that Met QC Criteria : April 22, 2016
First Posted : April 26, 2016 (Estimate)

Results First Submitted : February 26, 2019
Results First Submitted that Met QC Criteria : May 13, 2019
Results First Posted : May 15, 2019

Last Update Submitted that Met QC Criteria : August 14, 2020
Last Update Posted : August 27, 2020